Multiple Cancer Types - Featured Clinical Trials
- Targeted Treatment for Advanced Solid Tumors
(Posted: 12/16/2008) - This clinical trial combines the drug dasatinib with the angiogenesis inhibitor bevacizumab for patients with metastatic or unresectable solid tumors.
- Batracylin for Patients with Advanced Solid Tumors or Lymphoma
(Posted: 04/01/2008) - In this phase I trial, patients with solid tumors or lymphomas for which standard therapies do not exist or are of minimum benefit and who are slow acetylators, as determined by a blood test, will be treated with increasing doses of the drug batracylin.
- Inhibiting Tumor Angiogenesis in Children
(Posted: 01/22/2008) - In this trial, researchers are testing an angiogenesis inhibitor called cediranib in pediatric patients who have solid tumors (except brain tumors) or acute myeloid leukemia (AML), a type of blood cancer.
- Radiation Therapies to Treat Brain Metastases
(Posted: 08/21/2007) - In this clinical trial, doctors are comparing stereotactic radiosurgery alone against stereotactic radiosurgery followed by whole-brain radiotherapy in patients with 1-3 cerebral metastases resulting from cancer elsewhere in the body.
- New Targeted Therapy for Solid Tumors and Lymphomas
(Posted: 08/10/2004, Updated: 07/18/2007) - In this trial, researchers are trying to determine whether a new chemotherapy agent called 17-DMAG will help prevent cancer cells from growing in patients with solid tumors or lymphomas. The agent inhibits a protein called HSP-90 that is found more often in cancer cells than in normal cells.